PROM1 and cancer: In the present study, a 15-nucleotide base-pair CD133 aptamer targeting glycoprotein antigen CD133/AC133 in GSCs was conjugated to our Au-PEG-CB-839 platform in order to improve the targeting of cancer stem cells (Figure 1).